(Press-News.org) Engineered gut bacteria designed to treat kidney stones successfully colonized the gut microbiome and reduced oxalate levels in animal models and early clinical trials in humans, researchers report. The findings offer a promising, yet still imperfect, step toward microbial therapies. Efforts to manipulate the gut microbiome using engineered bacteria for therapeutic purposes have shown promise in animals, but often fail in clinical settings due to being hindered by inconsistent colonization. To overcome this challenge, Weston Whitaker and colleagues focused on Phocaeicola vulgatus, a common gut bacterium, and engineered it to consume the seaweed-derived nutrient, porphyran. Their previous work showed that adjusting dietary levels of a porphyran prebiotic can create a controllable niche that enables stable and tunable colonization of porphyran-metabolizing bacteria in the gut, which can be reversed when needed. Porphyran is rarely utilized by microbes in Western populations – only about 2% naturally carry bacteria with this capability, thus creating a largely unoccupied ecological niche for an engineered strain to thrive without competition. To evaluate whether this setup could be used to deliver microbial therapeutics, Whitaker et al. engineered a porphyran-metabolizing strain of P. vulgatus to break down oxalate (a cause of recurrent kidney stones) by introducing a specialized transporter and a metabolic pathway that converts oxalate into formate. In animal models and a phase 1/2a clinical trial in healthy humans, the authors show that engineered gut bacteria can safely and effectively colonize the gut and deliver therapeutic effects by reducing oxalate levels. However, some individuals developed persistent colonization due to genetic mutations, and notable horizontal gene transfer events compromised the strain’s therapeutic function. While the approach showed modest, early signs of reducing oxalate levels, challenges remain, Whitaker et al. note, including strain stability, biosafety, and competition from native microbes.
Podcast: A segment of Science's weekly podcast with Weston Whitaker, related to this research, will be available on the Science.org podcast landing page after the embargo lifts. Reporters are free to make use of the segments for broadcast purposes and/or quote from them – with appropriate attribution (i.e., cite "Science podcast"). Please note that the file itself should not be posted to any other Web site.
END
Controlled human gut colonization by an engineered microbial therapeutic
Summary author: Walter Beckwith
2025-07-17
ELSE PRESS RELEASES FROM THIS DATE:
Vaccination could mitigate climate-driven disruptions to malaria control
2025-07-17
Tropical cyclones in Madagascar lead to sharp spikes in malaria infections – particularly in children – due to interruptions in control efforts, according to a new study. However, the findings show that newly introduced long-lasting vaccines can help to mitigate these gaps. This points to pathways to climate-resilient control strategies in malaria-prone regions. Malaria, already a persistent global health challenge, poses new threats from climate change, not only through rising temperatures that shift mosquito dynamics but also via extreme weather events like tropical cyclones. Such disasters can severely ...
Smartphone-based earthquake detection and early warning system rivals traditional, seismic network based alternatives
2025-07-17
A global Android smartphone-based earthquake detection and early warning system can detect seismic activity in real time and deliver life-saving alerts with effectiveness rivaling that of traditional seismic networks, according to a new study. Despite our ability to predict where they are likely to occur, earthquakes continue to pose a serious threat to communities worldwide. Large-scale events can result in widespread loss of life and injury. These risks underscore the urgent need for protective measures including earthquake ...
First winner of AAAS-Chen Institute Prize builds tool to visualize biomolecular interactions
2025-07-17
For his work to help capture and view dynamic small-scale behaviors of biomolecules that have gone unseen – and which are critical to applications like drug development – Zhuoran Qiao has been awarded the inaugural Chen Institute and Science Prize for Al Accelerated Research. The prize recognizes innovative young researchers who apply techniques in artificial intelligence to help the research community solve important problems and accelerate their work.
“I was thrilled to partner with the Chen Institute to launch this new prize initiative,” said Yury V. Suleymanov, senior editor at Science. “Our winner, ...
Research spotlight: Study finds a protective kidney RNA that could transform disease treatment
2025-07-17
Q: How would you summarize your study for a lay audience?
Cells contain helper molecules called transfer RNAs (tRNAs), which carry building blocks (amino acids) to make proteins. These tRNAs can be broken down into smaller pieces called tRNA-derived RNAs (tsRNAs or tDRs) that have new jobs - to help cells deal with stress and challenging situations.
In this study, we focused on one specific tDR, called tRNA-Asp-GTC-3’tDR, which becomes more abundant during stress. tRNA-Asp-GTC-3’tDR is present at baseline in kidney cells and increases in response to disease-related stress signals in cell culture and several mouse models of kidney diseases. ...
Research Spotlight: Study reveals an unexpected role for protein aggregates in brain disease
2025-07-17
Raghu R. Chivukula, MD, PhD, a physician-investigator in the Departments of Medicine & Surgery and the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School, is the senior author of a paper published in Science, “Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.”
Q: How would you summarize your study for a lay audience?
Neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease, are devastating and incurable diseases. Although many neurodegenerative ...
UK Government and UK Research and Innovation join forces to launch multi-billion-pound compute roadmap
2025-07-17
Quicker health diagnoses, smarter energy supplies, tackling climate change and improved public service delivery – just some huge potential benefits of the new compute roadmap, launched by DSIT and UKRI.
The roadmap heralds a significant increase in publicly accessible compute capacity. Investments include up to £2 billion to deliver a holistic and user-centred compute ecosystem with £1 billion to expand the AI Research Resource 20-fold by 2030.
It also provides up to £750 million for UKRI to invest in a new national supercomputing service at Edinburgh.
UKRI is further ...
New study in JAMA Network Open shows current approaches to assessing preeclampsia risk are failing the majority of pregnant moms
2025-07-17
South San Francisco, CA (July 17, 2025) - A new study sponsored by Mirvie, which is the first to evaluate U.S. Preventive Services Task Force (USPSTF) guidelines for preeclampsia risk and aspirin prescription in a single, nationally representative, prospective population, found while high-risk factors had sufficient value in estimating risk, there’s limited value for the moderate risk category - leading to nonspecific recommendations for aspirin use, a recognized prevention tool.
This cohort study of 5684 participants, culled from the multi-center Miracle of Life prospective study, found the guidelines ...
An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
2025-07-17
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer.
The study, published in JAMA Network Open in collaboration with researchers at Mayo Clinic in Arizona, found that the absence of detectable tumors after treatment – a key metric in clinical cancer drug trials known as pathologic complete response or pCR – does not reliably predict an improvement in long-term survival for patients diagnosed with ...
Research Spotlight: evaluating the effectiveness of guidelines to predict the risk of preeclampsia
2025-07-17
Q: How would you summarize your study for a lay audience?
Dr. McElrath: Preeclampsia (PE) is a hypertensive disease that complicates 7-10% of pregnancies. While recent advances in understanding the underlying causes of PE have been made, predicting its occurrence has historically been difficult because it is a complex condition that likely results from a variety of causes and can present in different ways.
To address this challenge, the United States Preventive Services Task Force (USPSTF) reviewed ...
Pigment researchers create vivid yellows, oranges, reds that are durable, non-toxic
2025-07-17
CORVALLIS, Ore. – Oregon State University pigment researchers are using a rare mineral discovered in Norway more than a century ago as a road map for creating new yellows, oranges and reds that are vibrant, durable, non-toxic and inexpensive.
The new pigments also carry energy-saving potential: Their ability to reflect heat from the sun means that buildings and vehicles coated in them will require less air conditioning.
The study led by Mas Subramanian, who made color history in 2009 with the discovery of a vivid blue pigment now known commercially as YInMn Blue, was published in Chemistry of Materials.
Funded by the National Science Foundation, ...
LAST 30 PRESS RELEASES:
Participation of women in cardiovascular trials from 2017 to 2023
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Changes in biology of internal fat may be the leading cause of heart failure
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
One shot of RSV vaccine effective against hospitalization in older adults for two seasons
Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults
Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis
Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine
High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
Retinitis pigmentosa mouse models reflect pathobiology of human RP59
Cell’s ‘antenna’ could be key to curing diseases
Tiny ocean partnership between algae and bacteria reveals secrets of evolution
[Press-News.org] Controlled human gut colonization by an engineered microbial therapeuticSummary author: Walter Beckwith